Market Overview

Trilliant Health Targets New Healthcare Providers by Raising Additional Growth Capital

Share:

Noro-Moseley Partners Completes Series A Funding for Analytics Company

Trilliant Health, an analytics company that empowers healthcare
providers to create and execute data-driven strategies to maximize
revenue and market share growth, today announced they have completed
their Series A financing of over $12 million, consisting of more than $7
million of new equity capital, led by Noro-Moseley Partners, with
participation from existing investors Martin Ventures, Nashville Capital
Network, and NueCura Partners.

Trilliant Health will use the funding to continue building its data
science and technology teams to enhance the capabilities of its
analytics platform. The Trilliant analytics platform uses advanced data
science to combine claims data, household data, and user-generated data
from digital marketing campaigns to support healthcare systems around
strategy, site selection, M&A, payer negotiations, physician
relationship management, marketing, and employer relationship
management. Today, the company works with over 60 healthcare systems
across the nation to build and execute on their growth strategies.

"Trilliant Health turns analytics into highly differentiated insights
and intelligence to help healthcare providers better understand their
individual market dynamics," said Spence McClelland, General Partner at
Noro-Moseley Partners. "The Trilliant leadership team and investor group
have some of the strongest backgrounds and expertise in healthcare. This
healthcare experience, combined with the deep bench of data science,
technology, and product teams, positions Trilliant to transform the way
healthcare systems approach growth. If I were a healthcare system
executive needing to grow revenue and market share, I would seek a
trusted advisor that has a proven track record."

"While the data science may be complex, the strategy isn't. Hospitals
and ambulatory centers need patients. Patients need care. Trilliant
helps hospitals and ambulatory centers find, engage, and retain patients
in need of care," said Charles Martin, Jr., Founder and Chairman of
Martin Ventures. "It's always been the vision of Trilliant to leverage
data and technology to bring together strategy and execution. The
Trilliant analytics and data science platform provides insights to build
a growth strategy. The Trilliant technology products, including Customer
Relationship Management (CRM), Lead Management (LM), Physician
Relationship Management (PRM), and Employer Relationship Management
(ERM), provide the ability to execute on those strategies and insights."

"We are excited to add Noro-Moseley Partners to our already impressive
list of investors and partners," said Hal Andrews, CEO of Trilliant
Health. "In an environment of relentless reimbursement cuts, rising
expenses, and increasing competition, healthcare providers need
strategies to find the most efficient and effective solutions for growth
more than ever. Trilliant is that growth partner for health systems and
other healthcare providers. This capital will help us achieve our goals."

About Trilliant Health

Trilliant Health is an analytics company that empowers intelligent
patient acquisition. By synthesizing all-payer claims, household, and
patient-generated data, Trilliant Health provides a comprehensive view
into market dynamics that enables healthcare providers to find the most
efficient and effective solutions for growth in their markets.
For more information, please visit trillianthealth.com.

View Comments and Join the Discussion!